These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8264825)

  • 1. [Risk factors for the development of recurrences in patients with breast carcinoma without axillary lymph node metastases].
    Akkersdijk WL; Pieters JH; Smits JG; de Kruif JT; van der Tweel I; de Graaf PW
    Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2391-5. PubMed ID: 8264825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
    Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
    Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour.
    Colpaert C; Vermeulen P; Jeuris W; van Beest P; Goovaerts G; Weyler J; Van Dam P; Dirix L; Van Marck E
    J Pathol; 2001 Apr; 193(4):442-9. PubMed ID: 11276002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.